by John A. Jenkins | Nov 16, 2026 | FOIA, Stock Market
FOIAengine: New Questions About Super Micro, Nvidia, and Andrew Left’s Fraud Conviction Expose the Uneasy Relationship Between Activist Short Sellers and Prosecutors Andrew Left, one of Wall Street’s best-known short sellers, faces up to 25 years in...
by John A. Jenkins | Aug 5, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Stock Market
FOIAengine: Requests from Point72, Sofinnova, Holocene, Triple Gate and Others A review of the latest Freedom of Information Act requests targeting three life-sciences companies – Novo Nordisk (NYSE: NVO); Charles River Laboratories (NYSE: CRL); and iRhythm...
by John A. Jenkins | Jun 17, 2026 | FOIA, Hedge Funds, SEC, Short-Selling, Stock Market
FOIA Requests Offer Signals, and a Requester Provides Names Activist short seller Andrew Left always had a taste for risk. So, with his freedom and fortune on the line a few weeks ago in a Los Angeles courtroom, Left tried to beat the federal securities fraud charges...
by Randy Miller | May 6, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market
FOIAengine: Assessments Include Operational, Clinical and Commercial Threats Freedom of Information Act requests to the Food and Drug Administration during March illustrated three of the primary uncertainties facing U.S. drug manufacturers and their investors: the...
by John A. Jenkins | Apr 9, 2026 | FDA, FOIA, Litigation, Medical Devices, Short-Selling, Stock Market
How FOIA Requests Signaled Problems With a “Bionic Pancreas” At a federal advisory panel meeting in 2018, a biomedical engineer named Ed Damiano stepped to the microphone – not just as a scientist. “I’m also a father,” he told regulators, describing his son’s...
by John A. Jenkins | Feb 4, 2026 | FDA, FOIA, Litigation, Pharmaceuticals, Stock Market
FOIAengine: Media Requests Were Warnings, Months Before Bad News Hit In the early days of the Covid pandemic, there was big money on the line as pharmaceutical companies scrambled to produce vaccines. The world needed a miracle. The companies that could deliver it...